8156 — Sinopharm Tech Holdings Cashflow Statement
0.000.00%
Last trade - 00:00- HK$117.23m
- HK$263.19m
- HK$41.28m
- 20
- 23
- 86
- 37
Annual cashflow statement for Sinopharm Tech Holdings, fiscal year end - June 30th, HKD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -165 | -111 | -94.2 | -11.4 | -20.3 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 153 | 76.8 | 64.4 | 93.1 | 13.7 |
| Discontinued Operations | |||||
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 27 | 17.6 | -9.46 | -78.9 | -4 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 23.9 | -6.21 | -36.8 | 4.73 | -9.25 |
| Capital Expenditures | -23.4 | -10.1 | -0.121 | 0 | -3.33 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0.004 | 5.07 | 0.036 | 0.002 | -1.53 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -23.4 | -5.05 | -0.085 | 0.002 | -4.86 |
| Financing Cash Flow Items | -14.5 | 20.6 | -2.48 | 0 | -0.023 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.299 | 12.5 | 32.2 | -4.52 | 15 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.1 | 0.736 | -4.49 | -1.22 | 0.864 |